The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a ...

Blue Monday originated from a publicity stunt, but seasonal affective disorder is a real affliction that affects millions of ...

Inauguration Day in photos, the allure of coffee shops, how to handle seasonal depression: Catch up on the day’s stories ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

Higher daily step counts were linked to fewer depressive symptoms and a lower risk for depression in a new meta-analysis.

Rebutting the serotonin theory of depression exposed an important gap in our knowledge. But Joanna Moncrieff's new book ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good ...

It's become increasingly clear that the gut microbiome can affect human health, including mental health. Which bacterial ...

The U.S. Food and Drug Administration on Tuesday approved the first nasal spray that will help with treating major depressive ...

A new report studied depression levels across Europe and in older and younger individuals, with the outlook for France ...